|
nasdaq:mgnx
|
104791
|
Apr 21st, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
392.00
|
Open
|
|
Apr 20th, 2024 11:46PM
|
Apr 20th, 2024 11:46PM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 20th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
392.00
|
Open
|
|
Apr 19th, 2024 11:43PM
|
Apr 20th, 2024 05:18PM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 19th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
393.00
|
Open
|
|
Apr 18th, 2024 11:50PM
|
Apr 18th, 2024 11:50PM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 18th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
393.00
|
Open
|
|
Apr 17th, 2024 11:59PM
|
Apr 18th, 2024 06:38PM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 17th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
393.00
|
Open
|
|
Apr 16th, 2024 11:41PM
|
Apr 17th, 2024 03:04PM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 16th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
393.00
|
Open
|
|
Apr 15th, 2024 11:37PM
|
Apr 16th, 2024 11:20AM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 15th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
393.00
|
Open
|
|
Apr 14th, 2024 11:32PM
|
Apr 15th, 2024 05:01PM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 14th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
392.00
|
Open
|
|
Apr 13th, 2024 11:21PM
|
Apr 14th, 2024 11:20AM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 13th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
392.00
|
Open
|
|
Apr 12th, 2024 11:13PM
|
Apr 13th, 2024 11:47AM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:mgnx
|
104791
|
Apr 12th, 2024 12:00AM
|
MacroGenics, Inc.
|
13K
|
392.00
|
Open
|
|
Apr 11th, 2024 11:18PM
|
Apr 12th, 2024 08:42AM
|
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 400+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
|
Open
|
Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
|
Open
|
9704 Medical Center Drive
|
Rockville
|
MD
|
US
|
20850
|
|
MacroGenics
|
Health Care
|
Pharmaceuticals & Biotechnology
|